Ascentage third round garners $150M for apoptosis cancer drugs

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 17, 2018 at 11:12 PM.

  1. #1 cafead, Jul 17, 2018 at 11:12 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Chinese biotech Ascentage has raised another $150 million for its pipeline of drugs designed to induce programmed cell death in cancer, which should keep it going for three years, according to its co-founder and CEO.

    article source
     
    Quote

Reply to Thread